Tapazole Oral Tablet 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tapazole: Oral tablet (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_3617.JPG
Tapazole 10mg Tab
King Pharmaceuticals Inc a Pfizer Company
Pill Identification: J95 
Drug Image file DrugItem_3617.JPG
Tapazole 10mg Tab
King Pharmaceuticals Inc a Pfizer Company
Pill Identification: J95 

What is this Medicine?

METHIMAZOLE (meth IM a zole) prevents the thyroid gland from producing too much thyroid hormone. It is used to treat a condition known as hyperthyroidism.

CVS Pharmacy Patient Statistics for Tapazole: Oral tablet(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Tapazole 10mg Tablet

NDC: 607930105
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Thyrotoxicosis, Graves' Disease, Hyperthyroidism

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Tapazole 10mg Tablet
Drug Image file DrugItem_2065.JPG
King Pharmaceuticals Inc a Pfizer Company
Pill Identification: J95 
Shape: round
Color: white
Drug Image file DrugItem_3617.JPG
King Pharmaceuticals Inc a Pfizer Company
Pill Identification: J95 
Shape: round
Color: white

Reported Side Effects for Tapazole 10mg Tablet

Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<25.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pancytopenia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hepatic Encephalopathy Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
3.0-5.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Darkened Skin Patches Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
3.0-5.0%*
Severity: MILD
Onset: RAPID
Hair Loss Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tapazole

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5